Celexa and Ezetimibe drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Celexa (citalopram hydrobromide) and Ezetimibe (ezetimibe). Common drug interactions include peripheral swelling among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Celexa and Ezetimibe. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Celexa?

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.



On Jul, 28, 2026

47 people who take Celexa and Ezetimibe together, and have interactions are studied.

Celexa and Ezetimibe drug interactions.

What are the common drug interactions of Celexa and Ezetimibe, by gender? *:

female:

  1. Peripheral swelling
  2. Generalised oedema (swelling all over the body)
  3. Hypervolaemia (abnormally increased volume of blood)
  4. Joint swelling
  5. Fall
  6. Fungal infection
  7. Hyperlipidaemia (presence of excess lipids in the blood)
  8. Pain
  9. Acute respiratory failure
  10. Blood pressure fluctuation

male:

  1. Hypotension (abnormally low blood pressure)
  2. Nausea (feeling of having an urge to vomit)
  3. Dementia (madness)
  4. Hypertension (high blood pressure)
  5. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  6. Loss of consciousness
  7. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  8. Pain
  9. Pneumonia
  10. Renal failure acute (rapid kidney dysfunction)

What are the common drug interactions of Celexa and Ezetimibe, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Diabetes mellitus non-insulin-dependent
  2. Weight increased

30-39:

n/a

40-49:

  1. Complication of device insertion
  2. Procedural pain

50-59:

  1. Incisional hernia (hernia caused by an incompletely-healed surgical wound)
  2. Injection site pain
  3. Malignant neoplasm progression (cancer tumour came back)
  4. Metastases to liver (cancer spreads to liver)
  5. Metastasis (spreadable cancer to other organ from origin)
  6. Nausea (feeling of having an urge to vomit)
  7. Postoperative wound infection
  8. Second primary malignancy (after getting cure a cancer, a new cancer development)
  9. Skin cancer
  10. Staphylococcal infection (an infection with staphylococcus bacteria)

60+:

  1. Hypertension (high blood pressure)
  2. Hypotension (abnormally low blood pressure)
  3. Nausea (feeling of having an urge to vomit)
  4. Pneumonia
  5. Vomiting
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Dyspnoea (difficult or laboured respiration)
  8. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  9. Loss of consciousness
  10. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 6 people, 12.77%
  2. Neuroendocrine Tumor: 4 people, 8.51%
  3. Type 2 Diabetes: 3 people, 6.38%
  4. Osteoporosis (bones weak and more likely to break): 3 people, 6.38%
  5. Hiv Infection: 3 people, 6.38%
  6. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Celexa and Ezetimibe?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Celexa and Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ezetimibe and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide and ezetimibe (the active ingredients of Celexa and Ezetimibe, respectively), and Celexa and Ezetimibe (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: